Annual Operating Expenses
$221.85 M
+$24.80 M+12.58%
December 31, 2024
Summary
- As of March 12, 2025, NAMS annual total operating expenses is $221.85 million, with the most recent change of +$24.80 million (+12.58%) on December 31, 2024.
- During the last 3 years, NAMS annual operating expenses has risen by +$187.20 million (+540.25%).
- NAMS annual operating expenses is now at all-time high.
Performance
NAMS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$59.21 M
+$6.23 M+11.75%
December 31, 2024
Summary
- As of March 12, 2025, NAMS quarterly total operating expenses is $59.21 million, with the most recent change of +$6.23 million (+11.75%) on December 31, 2024.
- Over the past year, NAMS quarterly operating expenses has increased by +$6.23 million (+11.75%).
- NAMS quarterly operating expenses is now at all-time high.
Performance
NAMS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NAMS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.6% | +11.8% |
| 3 y3 years | +540.3% | +11.8% |
| 5 y5 years | +3317.5% | +11.8% |
NAMS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +540.3% | at high | +45.4% |
| 5 y | 5-year | at high | +3317.5% | at high | +45.4% |
| alltime | all time | at high | +3317.5% | at high | +45.4% |
NewAmsterdam Pharma Company NV Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $221.85 M(+12.6%) | $59.21 M(+11.8%) |
| Sep 2024 | - | $52.98 M(-1.3%) |
| Jun 2024 | - | $53.68 M(-4.1%) |
| Mar 2024 | - | $55.99 M(-3.2%) |
| Dec 2023 | $197.06 M | $57.86 M(+13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $51.22 M(+25.8%) |
| Jun 2023 | - | $40.72 M(-13.8%) |
| Mar 2023 | - | $47.26 M |
| Dec 2022 | $106.25 M(+206.6%) | - |
| Dec 2021 | $34.65 M(+433.8%) | - |
| Dec 2020 | $6.49 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total operating expenses?
- What is the all time high annual operating expenses for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual operating expenses year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly operating expenses year-on-year change?
What is NewAmsterdam Pharma Company NV annual total operating expenses?
The current annual operating expenses of NAMS is $221.85 M
What is the all time high annual operating expenses for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total operating expenses is $221.85 M
What is NewAmsterdam Pharma Company NV annual operating expenses year-on-year change?
Over the past year, NAMS annual total operating expenses has changed by +$24.80 M (+12.58%)
What is NewAmsterdam Pharma Company NV quarterly total operating expenses?
The current quarterly operating expenses of NAMS is $59.21 M
What is the all time high quarterly operating expenses for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total operating expenses is $59.21 M
What is NewAmsterdam Pharma Company NV quarterly operating expenses year-on-year change?
Over the past year, NAMS quarterly total operating expenses has changed by +$6.23 M (+11.75%)